198 related articles for article (PubMed ID: 9608360)
1. Enzymatic and kinetic properties of blood coagulation factor XIIIa and guinea pig liver transglutaminase utilizing (6-[N-(4-aminobutyl)-N-ethylamino]-2,3-dihydrophthalazine-1,4-dione, as a novel, specific and sensitive chemiluminescent substrate.
Achyuthan KE
J Biolumin Chemilumin; 1998; 13(1):1-11. PubMed ID: 9608360
[TBL] [Abstract][Full Text] [Related]
2. Thiols enhance the sensitivity of luminescent assays for non-cross-linked and covalently cross-linked aminophthalhydrazides.
Achyuthan KE
Luminescence; 2001; 16(4):257-62. PubMed ID: 11512140
[TBL] [Abstract][Full Text] [Related]
3. A microtiter plate transglutaminase assay utilizing 5-(biotinamido)pentylamine as substrate.
Slaughter TF; Achyuthan KE; Lai TS; Greenberg CS
Anal Biochem; 1992 Aug; 205(1):166-71. PubMed ID: 1359806
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of aminophthalhydrazides chemiluminescence by N-beta-alanyl-L-histidine (L-carnosine).
Achyuthan KE
Luminescence; 1999; 14(2):75-81. PubMed ID: 10398564
[TBL] [Abstract][Full Text] [Related]
5. Factor XIIIa-derived peptides inhibit transglutaminase activity. Localization of substrate recognition sites.
Achyuthan KE; Slaughter TF; Santiago MA; Enghild JJ; Greenberg CS
J Biol Chem; 1993 Oct; 268(28):21284-92. PubMed ID: 8104938
[TBL] [Abstract][Full Text] [Related]
6. Coagulation factor XIIIa undergoes a conformational change evoked by glutamine substrate. Studies on kinetics of inhibition and binding of XIIIA by a cross-reacting antifibrinogen antibody.
Mitkevich OV; Shainoff JR; DiBello PM; Yee VC; Teller DC; Smejkal GB; Bishop PD; Kolotushkina IS; Fickenscher K; Samokhin GP
J Biol Chem; 1998 Jun; 273(23):14387-91. PubMed ID: 9603949
[TBL] [Abstract][Full Text] [Related]
7. The comparative ability of plasma and tissue transglutaminases to use collagen as a substrate.
Jeleńska MM; Fesüs L; Kopeć M
Biochim Biophys Acta; 1980 Dec; 616(2):167-78. PubMed ID: 6111338
[TBL] [Abstract][Full Text] [Related]
8. Enhanced chemiluminescent assay for transglutaminases.
Achyuthan KE
Biotechniques; 1999 Mar; 26(3):435-8, 440-1. PubMed ID: 10090981
[No Abstract] [Full Text] [Related]
9. Structural features of glutamine substrates for human plasma factor XIIIa (activated blood coagulation factor XIII).
Gorman JJ; Folk JE
J Biol Chem; 1980 Jan; 255(2):419-27. PubMed ID: 6101325
[TBL] [Abstract][Full Text] [Related]
10. Vitronectin is a substrate for transglutaminases.
Sane DC; Moser TL; Pippen AM; Parker CJ; Achyuthan KE; Greenberg CS
Biochem Biophys Res Commun; 1988 Nov; 157(1):115-20. PubMed ID: 2461707
[TBL] [Abstract][Full Text] [Related]
11. Structural features of glutamine substrates for transglutaminases. Role of extended interactions in the specificity of human plasma factor XIIIa and of the guinea pig liver enzyme.
Gorman JJ; Folk JE
J Biol Chem; 1984 Jul; 259(14):9007-10. PubMed ID: 6146608
[TBL] [Abstract][Full Text] [Related]
12. Structural features of glutamine substrates for transglutaminases. Specificities of human plasma factor XIIIa and the guinea pig liver enzyme toward synthetic peptides.
Gorman JJ; Folk JE
J Biol Chem; 1981 Mar; 256(6):2712-5. PubMed ID: 6110660
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of a modified colorimetric solid-phase microassay for measuring the activity of cellular and plasma (Factor XIII) transglutaminases.
Thomas V; El Alaoui S; Massignon D; Clément S; Simonet F; Quash G
Biotechnol Appl Biochem; 2006 Mar; 43(Pt 3):171-9. PubMed ID: 16313237
[TBL] [Abstract][Full Text] [Related]
14. Tridegin, a new peptidic inhibitor of factor XIIIa, from the blood-sucking leech Haementeria ghilianii.
Finney S; Seale L; Sawyer RT; Wallis RB
Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):797-805. PubMed ID: 9210403
[TBL] [Abstract][Full Text] [Related]
15. Identification of amine acceptor protein substrates of transglutaminase in liver extracts: use of 5-(biotinamido) pentylamine as a probe.
Ikura K; Kita K; Fujita I; Hashimoto H; Kawabata N
Arch Biochem Biophys; 1998 Aug; 356(2):280-6. PubMed ID: 9705218
[TBL] [Abstract][Full Text] [Related]
16. Human inter-α-inhibitor is a substrate for factor XIIIa and tissue transglutaminase.
Scavenius C; Sanggaard KW; Nikolajsen CL; Bak S; Valnickova Z; Thøgersen IB; Jensen ON; Højrup P; Enghild JJ
Biochim Biophys Acta; 2011 Dec; 1814(12):1624-30. PubMed ID: 21939789
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein (a) is a substrate for factor XIIIa and tissue transglutaminase.
Borth W; Chang V; Bishop P; Harpel PC
J Biol Chem; 1991 Sep; 266(27):18149-53. PubMed ID: 1680857
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of rat brain transglutaminase.
Ohashi H; Itoh Y; Birckbichler PJ; Takeuchi Y
J Biochem; 1995 Dec; 118(6):1271-8. PubMed ID: 8720146
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus fibronectin-binding protein serves as a substrate for coagulation factor XIIIa: evidence for factor XIIIa-catalyzed covalent cross-linking to fibronectin and fibrin.
Matsuka YV; Anderson ET; Milner-Fish T; Ooi P; Baker S
Biochemistry; 2003 Dec; 42(49):14643-52. PubMed ID: 14661977
[TBL] [Abstract][Full Text] [Related]
20. In vitro modification of betaine-homocysteine S-methyltransferase by tissue-type transglutaminase.
Ichikawa A; Ohashi Y; Terada S; Natsuka S; Ikura K
Int J Biochem Cell Biol; 2004 Oct; 36(10):1981-92. PubMed ID: 15203112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
